About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
- WOMEN
- 2026 Readers' Choice Awards
Classifieds
Weather
Obituaries

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Kura Oncology, Inc. - Common Stock (NQ:KURA)

10.96 +1.02 (+10.21%)

Streaming Delayed Price Updated: 10:42 AM EDT, Aug 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kura Oncology, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Textron Posts Upbeat Earnings, Joins ASML, Progressive And Other Big Stocks Moving Higher On Wednesday ↗

January 24, 2024

U.S. stocks traded higher, with the Nasdaq Composite gaining around 100 points on Wednesday. Shares of Textron Inc. (NYSE: TXT) rose during Wednesday’s session following upbeat quarterly earnings.

Via Benzinga

Topics Stocks

Kura Oncology Rockets 39% Before Unveiling Cancer Drug Test Results — Here's Why ↗

January 24, 2024

Kura Oncology is still a week out from unveiling the results for an AML drug. But shares soared Wednesday.

Via Investor's Business Daily

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 24, 2024

Via Benzinga

Clinical Advancements In Kura Oncology's Lead Program Ziftomenib Hint at Upsurge in Success Likelihood: Analyst ↗

December 22, 2023

Mizuho initiated coverage on Kura Oncology Inc (NASDAQ: KURA), spotlighting the potential of ziftomenib as a first-in-class treatment for relapsed/refractory (r/r) NPM1-m acute myeloid leukemia...

Via Benzinga

A Preview Of Kura Oncology's Earnings ↗

November 01, 2023

Via Benzinga

Analyst Expectations for Kura Oncology's Future ↗

September 07, 2023

Via Benzinga

The Latest Analyst Ratings for Kura Oncology ↗

August 11, 2023

Via Benzinga

Where Kura Oncology Stands With Analysts ↗

July 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 27, 2023

Via Benzinga

Kura Oncology's Head & Neck Cancer Candidate Shows Meaningful Antitumor Activity In Pretreated Patients ↗

October 18, 2023

Kura Oncology Inc (NASDAQ: KURA) announced results from its registration-directed AIM-HN study of tipifarnib in patients with HRAS mutant head and neck squamous cell carcinoma (HNSCC) whose disease is...

Via Benzinga

Allarity Therapeutics Gaining Momentum? Hits Multiple Milestones Including Positive Publications In PLOS One And At ASCO, Positive Early Data From An Ongoing Clinical Trial, And External Partnering For Its DRP® Technology ↗

September 13, 2023

Allarity Therapeutics (NASDAQ: ALLR) is a biotechnology company focused on realizing true personalized cancer care by developing targeted cancer therapies coupled with companion diagnostics.

Via Benzinga

Sushi, Bans, And Business: Japan's Radioactive Water Release Sparks Concerns For US Seafood Traders ↗

August 25, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023 ↗

August 11, 2023

Via Benzinga

Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday ↗

August 04, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

7 Best Cancer Stocks to Invest in Now

July 28, 2023

The second-largest cause of death in the U.S., more than 600,000 deaths from cancer will occur in 2023. Learn about the best cancer stocks to invest in now.

Via MarketBeat

Topics Death

Over $27M Bet On Zymeworks? Check Out These 3 Stocks Insiders Are Buying ↗

June 22, 2023

Although US stocks closed lower on Wednesday, there were a few notable insider trades.

Via Benzinga

Analyst Ratings for Kura Oncology ↗

June 12, 2023

Via Benzinga

Kura Oncology: Q1 Earnings Insights ↗

May 10, 2023

Via Benzinga

Kura Oncology's Earnings Outlook ↗

February 22, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023 ↗

July 27, 2023

Via Benzinga

MicroVision, RadNet And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

June 14, 2023

U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session. MicroVision, Inc. (NASDAQ: MVIS) shares dropped 12.7% to $5.56 in...

Via Benzinga

Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 14, 2023

Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares climbed 140.3% to $20.28. WeTrade launched large-scale language processing models to increase product applications in the field of artificial...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2023 ↗

May 17, 2023

Via Benzinga

3 Under-the-Radar Stocks That AI Predicts Will Soar in May ↗

May 01, 2023

We enlisted the support of the generative AI chatbot that powers Bing chat to find under-the-radar stocks to buy

Via InvestorPlace

First Majestic Silver, Immatics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

March 21, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

7 Undiscovered Stocks to Watch for the Next Big Thing ↗

February 12, 2023

If you have a tolerance for risk and are willing to look for hot stocks to trade, here are some to the top stocks to watch.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2023 ↗

January 31, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 24, 2023

Via Benzinga

Why Kura Oncology Stock Is Moving Higher Tuesday Morning ↗

January 24, 2023

Kura Oncology Inc (NASDAQ: KURA) shares are trading higher Tuesday after the company announced the FDA clearance of its Inve

Via Benzinga

Cramer Is Holding This Biotech Stock ↗

January 12, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended holding Biomarin Pharmaceutical Inc (NASDAQ: BMRN).

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Kura Oncology, Inc. - Common Stock (NQ:KURA)

All News about Kura Oncology, Inc. - Common Stock

Sections

Services

Contact Information

Follow Us